Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2018-12-03 17:45 |
AMOEBA announces the signature of an amendment to the contract for the issuance…
|
English | PDF • 191.9 KB | ||
| 2018-11-29 16:39 |
AMOEBA announces the result of the European vote on the non-approval and inform…
|
English | PDF • 130.2 KB | ||
| 2018-11-29 16:33 |
AMOEBA annonce le résultat du vote européen relatif à la non-approbation et inf…
|
French | PDF • 290.1 KB | ||
| 2018-11-07 17:40 |
Amoeba announces the results of a safety & efficacy study assessing the fate of…
|
English | PDF • 377.9 KB | ||
| 2018-11-07 17:40 |
Amoeba annonce les résultats d'une étude d'efficacité et de sécurité sur le dev…
|
French | PDF • 411.4 KB | ||
| 2018-06-08 17:45 |
ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 21 JUIN 2018
|
French | PDF • 175.5 KB | ||
| 2018-06-08 17:45 |
1 PRESS RELEASE Lyon, 8th June 2018 ORDINARY AND EXTRAORDINARY ANNUAL GENERAL M…
|
English | PDF • 169.7 KB | ||
| 2018-06-05 17:45 |
AMOEBA annonce la publication de l’opinion du Comité des Produits Biocides
|
French | PDF • 170.5 KB | ||
| 2018-06-05 17:45 |
AMOEBA informs of the release of the Biocidal Products Committee opinion
|
English | PDF • 139.3 KB | ||
| 2018-05-25 18:00 |
AMOEBA annonce son projet de restructuration
|
French | PDF • 149.2 KB | ||
| 2018-05-25 18:00 |
AMOEBA announces its project of restructuring
|
English | PDF • 142.1 KB | ||
| 2018-05-15 11:31 |
Franchissement de seuils
|
French | PDF • 19.9 KB | ||
| 2018-05-04 17:48 |
AMOEBA annonce des résultats d’efficacité de Willaertia magna C2c Maky en serre…
|
French | PDF • 157.8 KB | ||
| 2018-04-27 18:44 |
Amoeba annonce la publication de son document de référence de l'exercice 2017.
|
French | PDF • 161.0 KB | ||
| 2018-04-27 18:41 |
Amoeba : Document de référence 2017.
|
French | PDF • 3.3 MB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
